Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2026(Status and Outlook)
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.Global Onychomycosis (Tinea Unguium) Drug key players include Pfizer, J&J, Novartis, Galderma pharm, Valeant Pharma, etc. Global top five manufacturers hold a share about 35%.North America is the largest market, with a share about 30%, followed by Europe and China both have a share over 45 percent. In terms of product, Oral Medication is the largest segment, with a share over 70%. And in terms of application, the largest application is Age above 50, followed by Age under 18.
The global Onychomycosis (Tinea Unguium) Drug market size was estimated at USD 3677.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Onychomycosis (Tinea Unguium) Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Onychomycosis (Tinea Unguium) Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Onychomycosis (Tinea Unguium) Drug market.
Global Onychomycosis (Tinea Unguium) Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg
Market Segmentation (by Type)
Oral Medication
External Medicine
Market Segmentation (by Application)
Age under 18
Age 18-50
Age above 50
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Onychomycosis (Tinea Unguium) Drug Market
Overview of the regional outlook of the Onychomycosis (Tinea Unguium) Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Onychomycosis (Tinea Unguium) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Onychomycosis (Tinea Unguium) Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Onychomycosis (Tinea Unguium) Drug market size was estimated at USD 3677.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Onychomycosis (Tinea Unguium) Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Onychomycosis (Tinea Unguium) Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Onychomycosis (Tinea Unguium) Drug market.
Global Onychomycosis (Tinea Unguium) Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg
Market Segmentation (by Type)
Oral Medication
External Medicine
Market Segmentation (by Application)
Age under 18
Age 18-50
Age above 50
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Onychomycosis (Tinea Unguium) Drug Market
Overview of the regional outlook of the Onychomycosis (Tinea Unguium) Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Onychomycosis (Tinea Unguium) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Onychomycosis (Tinea Unguium) Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Key Market Segments
1.2.1 Onychomycosis (Tinea Unguium) Drug Segment by Type
1.2.2 Onychomycosis (Tinea Unguium) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Onychomycosis (Tinea Unguium) Drug Product Life Cycle
3.3 Global Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2020-2025)
3.4 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Onychomycosis (Tinea Unguium) Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Onychomycosis (Tinea Unguium) Drug Market Competitive Situation and Trends
3.8.1 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Onychomycosis (Tinea Unguium) Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Onychomycosis (Tinea Unguium) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Onychomycosis (Tinea Unguium) Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Onychomycosis (Tinea Unguium) Drug Market
5.7 ESG Ratings of Leading Companies
6 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2020-2025)
6.3 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (2020-2025)
6.4 Global Onychomycosis (Tinea Unguium) Drug Price by Type (2020-2025)
7 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Onychomycosis (Tinea Unguium) Drug Market Sales by Application (2020-2025)
7.3 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2020-2025)
8 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SALES BY REGION
8.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
8.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
8.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region
8.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.2.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.3 North America
8.3.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Country
8.3.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country
8.4.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region
8.5.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Onychomycosis (Tinea Unguium) Drug Sales by Country
8.6.2 South America Onychomycosis (Tinea Unguium) Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Region
8.7.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Onychomycosis (Tinea Unguium) Drug by Region(2020-2025)
9.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2020-2025)
9.3 Global Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Onychomycosis (Tinea Unguium) Drug Production
9.4.1 North America Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2020-2025)
9.4.2 North America Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Onychomycosis (Tinea Unguium) Drug Production
9.5.1 Europe Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2020-2025)
9.5.2 Europe Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Onychomycosis (Tinea Unguium) Drug Production (2020-2025)
9.6.1 Japan Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2020-2025)
9.6.2 Japan Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Onychomycosis (Tinea Unguium) Drug Production (2020-2025)
9.7.1 China Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2020-2025)
9.7.2 China Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Overview
10.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Yangtze River
10.2.1 Yangtze River Basic Information
10.2.2 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Overview
10.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.2.4 Yangtze River Business Overview
10.2.5 Yangtze River SWOT Analysis
10.2.6 Yangtze River Recent Developments
10.3 Torrent Pharma
10.3.1 Torrent Pharma Basic Information
10.3.2 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
10.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.3.4 Torrent Pharma Business Overview
10.3.5 Torrent Pharma SWOT Analysis
10.3.6 Torrent Pharma Recent Developments
10.4 JandJ
10.4.1 JandJ Basic Information
10.4.2 JandJ Onychomycosis (Tinea Unguium) Drug Product Overview
10.4.3 JandJ Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.4.4 JandJ Business Overview
10.4.5 JandJ Recent Developments
10.5 Chengdu Brilliant
10.5.1 Chengdu Brilliant Basic Information
10.5.2 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Overview
10.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.5.4 Chengdu Brilliant Business Overview
10.5.5 Chengdu Brilliant Recent Developments
10.6 Novartis
10.6.1 Novartis Basic Information
10.6.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Overview
10.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 Qilu Pharmaceutical
10.7.1 Qilu Pharmaceutical Basic Information
10.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
10.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.7.4 Qilu Pharmaceutical Business Overview
10.7.5 Qilu Pharmaceutical Recent Developments
10.8 Xiuzheng Pharmaceutical
10.8.1 Xiuzheng Pharmaceutical Basic Information
10.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
10.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.8.4 Xiuzheng Pharmaceutical Business Overview
10.8.5 Xiuzheng Pharmaceutical Recent Developments
10.9 Hubei Hengan
10.9.1 Hubei Hengan Basic Information
10.9.2 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Overview
10.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.9.4 Hubei Hengan Business Overview
10.9.5 Hubei Hengan Recent Developments
10.10 TARO
10.10.1 TARO Basic Information
10.10.2 TARO Onychomycosis (Tinea Unguium) Drug Product Overview
10.10.3 TARO Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.10.4 TARO Business Overview
10.10.5 TARO Recent Developments
10.11 Perrigo
10.11.1 Perrigo Basic Information
10.11.2 Perrigo Onychomycosis (Tinea Unguium) Drug Product Overview
10.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.11.4 Perrigo Business Overview
10.11.5 Perrigo Recent Developments
10.12 Galderma pharm
10.12.1 Galderma pharm Basic Information
10.12.2 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Overview
10.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.12.4 Galderma pharm Business Overview
10.12.5 Galderma pharm Recent Developments
10.13 Zhejiang Deyer
10.13.1 Zhejiang Deyer Basic Information
10.13.2 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Overview
10.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.13.4 Zhejiang Deyer Business Overview
10.13.5 Zhejiang Deyer Recent Developments
10.14 Valeant Pharma
10.14.1 Valeant Pharma Basic Information
10.14.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
10.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.14.4 Valeant Pharma Business Overview
10.14.5 Valeant Pharma Recent Developments
10.15 Moberg
10.15.1 Moberg Basic Information
10.15.2 Moberg Onychomycosis (Tinea Unguium) Drug Product Overview
10.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.15.4 Moberg Business Overview
10.15.5 Moberg Recent Developments
11 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST BY REGION
11.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast
11.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country
11.2.3 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region
11.2.4 South America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Onychomycosis (Tinea Unguium) Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Onychomycosis (Tinea Unguium) Drug by Type (2026-2035)
12.1.2 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Onychomycosis (Tinea Unguium) Drug by Type (2026-2035)
12.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2026-2035)
12.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Application
12.2.2 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Key Market Segments
1.2.1 Onychomycosis (Tinea Unguium) Drug Segment by Type
1.2.2 Onychomycosis (Tinea Unguium) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Onychomycosis (Tinea Unguium) Drug Product Life Cycle
3.3 Global Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2020-2025)
3.4 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Onychomycosis (Tinea Unguium) Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Onychomycosis (Tinea Unguium) Drug Market Competitive Situation and Trends
3.8.1 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Onychomycosis (Tinea Unguium) Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Onychomycosis (Tinea Unguium) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Onychomycosis (Tinea Unguium) Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Onychomycosis (Tinea Unguium) Drug Market
5.7 ESG Ratings of Leading Companies
6 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2020-2025)
6.3 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (2020-2025)
6.4 Global Onychomycosis (Tinea Unguium) Drug Price by Type (2020-2025)
7 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Onychomycosis (Tinea Unguium) Drug Market Sales by Application (2020-2025)
7.3 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2020-2025)
8 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SALES BY REGION
8.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
8.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
8.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region
8.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.2.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.3 North America
8.3.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Country
8.3.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country
8.4.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region
8.5.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Onychomycosis (Tinea Unguium) Drug Sales by Country
8.6.2 South America Onychomycosis (Tinea Unguium) Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Region
8.7.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Onychomycosis (Tinea Unguium) Drug by Region(2020-2025)
9.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2020-2025)
9.3 Global Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Onychomycosis (Tinea Unguium) Drug Production
9.4.1 North America Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2020-2025)
9.4.2 North America Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Onychomycosis (Tinea Unguium) Drug Production
9.5.1 Europe Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2020-2025)
9.5.2 Europe Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Onychomycosis (Tinea Unguium) Drug Production (2020-2025)
9.6.1 Japan Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2020-2025)
9.6.2 Japan Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Onychomycosis (Tinea Unguium) Drug Production (2020-2025)
9.7.1 China Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2020-2025)
9.7.2 China Onychomycosis (Tinea Unguium) Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Overview
10.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Yangtze River
10.2.1 Yangtze River Basic Information
10.2.2 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Overview
10.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.2.4 Yangtze River Business Overview
10.2.5 Yangtze River SWOT Analysis
10.2.6 Yangtze River Recent Developments
10.3 Torrent Pharma
10.3.1 Torrent Pharma Basic Information
10.3.2 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
10.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.3.4 Torrent Pharma Business Overview
10.3.5 Torrent Pharma SWOT Analysis
10.3.6 Torrent Pharma Recent Developments
10.4 JandJ
10.4.1 JandJ Basic Information
10.4.2 JandJ Onychomycosis (Tinea Unguium) Drug Product Overview
10.4.3 JandJ Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.4.4 JandJ Business Overview
10.4.5 JandJ Recent Developments
10.5 Chengdu Brilliant
10.5.1 Chengdu Brilliant Basic Information
10.5.2 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Overview
10.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.5.4 Chengdu Brilliant Business Overview
10.5.5 Chengdu Brilliant Recent Developments
10.6 Novartis
10.6.1 Novartis Basic Information
10.6.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Overview
10.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 Qilu Pharmaceutical
10.7.1 Qilu Pharmaceutical Basic Information
10.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
10.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.7.4 Qilu Pharmaceutical Business Overview
10.7.5 Qilu Pharmaceutical Recent Developments
10.8 Xiuzheng Pharmaceutical
10.8.1 Xiuzheng Pharmaceutical Basic Information
10.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
10.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.8.4 Xiuzheng Pharmaceutical Business Overview
10.8.5 Xiuzheng Pharmaceutical Recent Developments
10.9 Hubei Hengan
10.9.1 Hubei Hengan Basic Information
10.9.2 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Overview
10.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.9.4 Hubei Hengan Business Overview
10.9.5 Hubei Hengan Recent Developments
10.10 TARO
10.10.1 TARO Basic Information
10.10.2 TARO Onychomycosis (Tinea Unguium) Drug Product Overview
10.10.3 TARO Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.10.4 TARO Business Overview
10.10.5 TARO Recent Developments
10.11 Perrigo
10.11.1 Perrigo Basic Information
10.11.2 Perrigo Onychomycosis (Tinea Unguium) Drug Product Overview
10.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.11.4 Perrigo Business Overview
10.11.5 Perrigo Recent Developments
10.12 Galderma pharm
10.12.1 Galderma pharm Basic Information
10.12.2 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Overview
10.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.12.4 Galderma pharm Business Overview
10.12.5 Galderma pharm Recent Developments
10.13 Zhejiang Deyer
10.13.1 Zhejiang Deyer Basic Information
10.13.2 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Overview
10.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.13.4 Zhejiang Deyer Business Overview
10.13.5 Zhejiang Deyer Recent Developments
10.14 Valeant Pharma
10.14.1 Valeant Pharma Basic Information
10.14.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
10.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.14.4 Valeant Pharma Business Overview
10.14.5 Valeant Pharma Recent Developments
10.15 Moberg
10.15.1 Moberg Basic Information
10.15.2 Moberg Onychomycosis (Tinea Unguium) Drug Product Overview
10.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Product Market Performance
10.15.4 Moberg Business Overview
10.15.5 Moberg Recent Developments
11 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST BY REGION
11.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast
11.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country
11.2.3 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region
11.2.4 South America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Onychomycosis (Tinea Unguium) Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Onychomycosis (Tinea Unguium) Drug by Type (2026-2035)
12.1.2 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Onychomycosis (Tinea Unguium) Drug by Type (2026-2035)
12.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2026-2035)
12.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Application
12.2.2 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (M USD)
Table 4. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application
Table 5. Onychomycosis (Tinea Unguium) Drug Market Size Comparison by Region (M USD)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2025)
Table 11. Global Market Onychomycosis (Tinea Unguium) Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Onychomycosis (Tinea Unguium) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Onychomycosis (Tinea Unguium) Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Onychomycosis (Tinea Unguium) Drug Sales by Type (K MT)
Table 27. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (M USD)
Table 28. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2020-2025)
Table 30. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type (2020-2025)
Table 32. Global Onychomycosis (Tinea Unguium) Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Application
Table 34. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application
Table 35. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2020-2025)
Table 37. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2020-2025)
Table 39. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Onychomycosis (Tinea Unguium) Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2020-2025)
Table 42. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025)
Table 44. North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Onychomycosis (Tinea Unguium) Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Onychomycosis (Tinea Unguium) Drug Production (K MT) by Region(2020-2025)
Table 55. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Onychomycosis (Tinea Unguium) Drug Product Overview
Table 64. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Yangtze River Basic Information
Table 69. Yangtze River Onychomycosis (Tinea Unguium) Drug Product Overview
Table 70. Yangtze River Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Yangtze River Business Overview
Table 72. Yangtze River SWOT Analysis
Table 73. Yangtze River Recent Developments
Table 74. Torrent Pharma Basic Information
Table 75. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
Table 76. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Torrent Pharma Business Overview
Table 78. Torrent Pharma SWOT Analysis
Table 79. Torrent Pharma Recent Developments
Table 80. JandJ Basic Information
Table 81. JandJ Onychomycosis (Tinea Unguium) Drug Product Overview
Table 82. JandJ Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. JandJ Business Overview
Table 84. JandJ Recent Developments
Table 85. Chengdu Brilliant Basic Information
Table 86. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Overview
Table 87. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Chengdu Brilliant Business Overview
Table 89. Chengdu Brilliant Recent Developments
Table 90. Novartis Basic Information
Table 91. Novartis Onychomycosis (Tinea Unguium) Drug Product Overview
Table 92. Novartis Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Business Overview
Table 94. Novartis Recent Developments
Table 95. Qilu Pharmaceutical Basic Information
Table 96. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
Table 97. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Qilu Pharmaceutical Business Overview
Table 99. Qilu Pharmaceutical Recent Developments
Table 100. Xiuzheng Pharmaceutical Basic Information
Table 101. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
Table 102. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Xiuzheng Pharmaceutical Business Overview
Table 104. Xiuzheng Pharmaceutical Recent Developments
Table 105. Hubei Hengan Basic Information
Table 106. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Overview
Table 107. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Hubei Hengan Business Overview
Table 109. Hubei Hengan Recent Developments
Table 110. TARO Basic Information
Table 111. TARO Onychomycosis (Tinea Unguium) Drug Product Overview
Table 112. TARO Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. TARO Business Overview
Table 114. TARO Recent Developments
Table 115. Perrigo Basic Information
Table 116. Perrigo Onychomycosis (Tinea Unguium) Drug Product Overview
Table 117. Perrigo Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Perrigo Business Overview
Table 119. Perrigo Recent Developments
Table 120. Galderma pharm Basic Information
Table 121. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Overview
Table 122. Galderma pharm Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Galderma pharm Business Overview
Table 124. Galderma pharm Recent Developments
Table 125. Zhejiang Deyer Basic Information
Table 126. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Overview
Table 127. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Zhejiang Deyer Business Overview
Table 129. Zhejiang Deyer Recent Developments
Table 130. Valeant Pharma Basic Information
Table 131. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
Table 132. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Valeant Pharma Business Overview
Table 134. Valeant Pharma Recent Developments
Table 135. Moberg Basic Information
Table 136. Moberg Onychomycosis (Tinea Unguium) Drug Product Overview
Table 137. Moberg Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Moberg Business Overview
Table 139. Moberg Recent Developments
Table 140. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (M USD)
Table 4. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application
Table 5. Onychomycosis (Tinea Unguium) Drug Market Size Comparison by Region (M USD)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2025)
Table 11. Global Market Onychomycosis (Tinea Unguium) Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Onychomycosis (Tinea Unguium) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Onychomycosis (Tinea Unguium) Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Onychomycosis (Tinea Unguium) Drug Sales by Type (K MT)
Table 27. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (M USD)
Table 28. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2020-2025)
Table 30. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type (2020-2025)
Table 32. Global Onychomycosis (Tinea Unguium) Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Application
Table 34. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application
Table 35. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2020-2025)
Table 37. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2020-2025)
Table 39. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Onychomycosis (Tinea Unguium) Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2020-2025)
Table 42. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025)
Table 44. North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Onychomycosis (Tinea Unguium) Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Onychomycosis (Tinea Unguium) Drug Production (K MT) by Region(2020-2025)
Table 55. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Onychomycosis (Tinea Unguium) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Onychomycosis (Tinea Unguium) Drug Product Overview
Table 64. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Yangtze River Basic Information
Table 69. Yangtze River Onychomycosis (Tinea Unguium) Drug Product Overview
Table 70. Yangtze River Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Yangtze River Business Overview
Table 72. Yangtze River SWOT Analysis
Table 73. Yangtze River Recent Developments
Table 74. Torrent Pharma Basic Information
Table 75. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
Table 76. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Torrent Pharma Business Overview
Table 78. Torrent Pharma SWOT Analysis
Table 79. Torrent Pharma Recent Developments
Table 80. JandJ Basic Information
Table 81. JandJ Onychomycosis (Tinea Unguium) Drug Product Overview
Table 82. JandJ Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. JandJ Business Overview
Table 84. JandJ Recent Developments
Table 85. Chengdu Brilliant Basic Information
Table 86. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Overview
Table 87. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Chengdu Brilliant Business Overview
Table 89. Chengdu Brilliant Recent Developments
Table 90. Novartis Basic Information
Table 91. Novartis Onychomycosis (Tinea Unguium) Drug Product Overview
Table 92. Novartis Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Business Overview
Table 94. Novartis Recent Developments
Table 95. Qilu Pharmaceutical Basic Information
Table 96. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
Table 97. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Qilu Pharmaceutical Business Overview
Table 99. Qilu Pharmaceutical Recent Developments
Table 100. Xiuzheng Pharmaceutical Basic Information
Table 101. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
Table 102. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Xiuzheng Pharmaceutical Business Overview
Table 104. Xiuzheng Pharmaceutical Recent Developments
Table 105. Hubei Hengan Basic Information
Table 106. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Overview
Table 107. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Hubei Hengan Business Overview
Table 109. Hubei Hengan Recent Developments
Table 110. TARO Basic Information
Table 111. TARO Onychomycosis (Tinea Unguium) Drug Product Overview
Table 112. TARO Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. TARO Business Overview
Table 114. TARO Recent Developments
Table 115. Perrigo Basic Information
Table 116. Perrigo Onychomycosis (Tinea Unguium) Drug Product Overview
Table 117. Perrigo Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Perrigo Business Overview
Table 119. Perrigo Recent Developments
Table 120. Galderma pharm Basic Information
Table 121. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Overview
Table 122. Galderma pharm Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Galderma pharm Business Overview
Table 124. Galderma pharm Recent Developments
Table 125. Zhejiang Deyer Basic Information
Table 126. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Overview
Table 127. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Zhejiang Deyer Business Overview
Table 129. Zhejiang Deyer Recent Developments
Table 130. Valeant Pharma Basic Information
Table 131. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
Table 132. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Valeant Pharma Business Overview
Table 134. Valeant Pharma Recent Developments
Table 135. Moberg Basic Information
Table 136. Moberg Onychomycosis (Tinea Unguium) Drug Product Overview
Table 137. Moberg Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Moberg Business Overview
Table 139. Moberg Recent Developments
Table 140. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Onychomycosis (Tinea Unguium) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD), 2025-2035
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) (2020-2035)
Figure 6. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Onychomycosis (Tinea Unguium) Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Product Life Cycle
Figure 13. Onychomycosis (Tinea Unguium) Drug Sales Share by Manufacturers in 2025
Figure 14. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers in 2025
Figure 15. Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Onychomycosis (Tinea Unguium) Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Onychomycosis (Tinea Unguium) Drug Revenue in 2025
Figure 18. Industry Chain Map of Onychomycosis (Tinea Unguium) Drug
Figure 19. Global Onychomycosis (Tinea Unguium) Drug Market PEST Analysis
Figure 20. Global Onychomycosis (Tinea Unguium) Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type
Figure 27. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2020-2025)
Figure 28. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2025
Figure 29. Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2020-2025)
Figure 30. Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application
Figure 33. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2025
Figure 35. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2020-2025)
Figure 36. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application in 2025
Figure 37. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025)
Figure 40. North America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2024
Figure 43. North America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country in 2024
Figure 45. U.S. Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Onychomycosis (Tinea Unguium) Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Onychomycosis (Tinea Unguium) Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Onychomycosis (Tinea Unguium) Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2024
Figure 53. Europe Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country in 2024
Figure 55. Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region in 2024
Figure 68. China Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (K MT)
Figure 79. South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2024
Figure 80. South America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (M USD)
Figure 81. South America Onychomycosis (Tinea Unguium) Drug Market Size by Country in 2024
Figure 82. Brazil Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Region (2020-2025)
Figure 103. North America Onychomycosis (Tinea Unguium) Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Onychomycosis (Tinea Unguium) Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Onychomycosis (Tinea Unguium) Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Onychomycosis (Tinea Unguium) Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Onychomycosis (Tinea Unguium) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD), 2025-2035
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) (2020-2035)
Figure 6. Global Onychomycosis (Tinea Unguium) Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Onychomycosis (Tinea Unguium) Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Product Life Cycle
Figure 13. Onychomycosis (Tinea Unguium) Drug Sales Share by Manufacturers in 2025
Figure 14. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers in 2025
Figure 15. Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Onychomycosis (Tinea Unguium) Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Onychomycosis (Tinea Unguium) Drug Revenue in 2025
Figure 18. Industry Chain Map of Onychomycosis (Tinea Unguium) Drug
Figure 19. Global Onychomycosis (Tinea Unguium) Drug Market PEST Analysis
Figure 20. Global Onychomycosis (Tinea Unguium) Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type
Figure 27. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2020-2025)
Figure 28. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2025
Figure 29. Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2020-2025)
Figure 30. Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application
Figure 33. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2025
Figure 35. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2020-2025)
Figure 36. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application in 2025
Figure 37. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2020-2025)
Figure 40. North America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2024
Figure 43. North America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country in 2024
Figure 45. U.S. Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Onychomycosis (Tinea Unguium) Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Onychomycosis (Tinea Unguium) Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Onychomycosis (Tinea Unguium) Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2024
Figure 53. Europe Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country in 2024
Figure 55. Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region in 2024
Figure 68. China Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (K MT)
Figure 79. South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2024
Figure 80. South America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (M USD)
Figure 81. South America Onychomycosis (Tinea Unguium) Drug Market Size by Country in 2024
Figure 82. Brazil Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Region (2020-2025)
Figure 103. North America Onychomycosis (Tinea Unguium) Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Onychomycosis (Tinea Unguium) Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Onychomycosis (Tinea Unguium) Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Onychomycosis (Tinea Unguium) Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2026-2035)
